Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;278(6):1891-1897.
doi: 10.1007/s00405-020-06496-5. Epub 2020 Nov 25.

The temporal course of COVID-19 anosmia and relation to other clinical symptoms

Affiliations

The temporal course of COVID-19 anosmia and relation to other clinical symptoms

Aytug Altundag et al. Eur Arch Otorhinolaryngol. 2021 Jun.

Abstract

Objective: This study aimed to define the clinical course of anosmia in relation to other clinical symptoms.

Methods: 135 patients with COVID-19 were reached by phone and subsequently included in the study. Olfactory functions were evaluated using a questionnaire for assessment of self-reported olfactory function. Patients were divided into four subgroups according to the presence of olfactory symptoms and temporal relationship with the other symptoms: group1 had only olfactory complaints (isolated, sudden-onset loss of smell); group2 had sudden-onset loss of smell, followed by COVID-19 related complaints; group3 initially had COVID-19 related complaints, then gradually developed olfactory complaints; and group4 had no olfactory complaints.

Results: In total, 59.3% of the patients interviewed had olfactory complaints during the disease course. The olfactory dysfunction severity during COVID-19 infection was significantly higher in group1 compared to groups 2 and 3. In groups1-3, the odor scores after recovery from COVID-19 disease were significantly lower compared to the status prior to disease onset. The residual olfactory dysfunction was similar between groups1 and 2, but was more evident than group3. Mean duration for loss of smell was 7.8 ± 3.1 (2-15) days. Duration of loss of smell was longer in groups1 and 2 than in group3. Odor scores completely returned back to the pre-disease values in 41 (51.2%) patients with olfactory dysfunction. Rate of complete olfactory dysfunction recovery was higher in group3 compared to groups1 and 2.

Conclusion: In isolated anosmia cases, anosmia is more severe, and complete recovery rates are lower compared to the patients who have other clinical symptoms.

Level of evidence: Level 4.

Keywords: Anosmia; COVID-19; Olfactory dysfunction; Recoverable; Sudden.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Figures

Fig. 1
Fig. 1
Self-rating olfactory scores
Fig. 2
Fig. 2
The flowchart summarizing percentages of total loss of smell and complete recovery rates by groups

References

    1. World Health Organization (2020) Coronavirus disease 2019 (COVID-19): situation report. . https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... (Accessed Aug 30, 2020)
    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed
    1. Giacomelli A, Pezzati L, Conti F, et al. Self-reported Olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis. 2020;71:889–890. doi: 10.1093/cid/ciaa330. - DOI - PMC - PubMed
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-ınfected pneumonia in Wuhan China. JAMA. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
    1. Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58:299–301. doi: 10.4193/Rhin20.114. - DOI - PubMed